Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study.

Authors :: Poloni A
Capelli D
Trappolini S
Costantini B
Montanari M
Gini G
Scortechini I
Mancini G
Discepoli G
Leoni P
Olivieri A
Source :: British journal of haematology [Br J Haematol] 2010 Jul; Vol. 150 (1), pp. 119-21. Date of Electronic Publication: 2010 Apr 05.
Publication Year :: 2010

Subjects :: Aged
Antibodies, Monoclonal, Humanized
Female
Gemtuzumab
Humans
Male
Middle Aged
Pilot Projects
Survival Analysis
Treatment Outcome
Aminoglycosides therapeutic use
Antibodies, Monoclonal therapeutic use
Antineoplastic Agents therapeutic use
Leukemia, Myeloid, Acute drug therapy

Full Text Access

Tools